ML
Magic Lifescience develops a Point-of-Care (POC) Lab-on-Chip (LOC) Molecular Diagnostic (MDx) Analyzer utilizing Giant Magnetoresistance (GMR) biosensors. This platform delivers simultaneous pathogen identification and antimicrobial susceptibility (AMR) results in under 20 minutes. The system enables rapid, in-house susceptibility-guided therapy decisions near the patient.
San Francisco, United StatesFounded 2021
Updated 2 months ago
Funding
$163.4K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NI
Funding rounds are not available yet.
Founders
Product
Features
- Magic Lifescience develops a Point-of-Care (POC) Lab-on-Chip (LOC) Molecular Diagnostic (MDx) Analyzer utilizing Giant Magnetoresistance (GMR) biosensors. This platform delivers simultaneous pathogen identification and antimicrobial susceptibility (AMR) results in under 20 minutes. The system enables rapid, in-house susceptibility-guided therapy decisions near the patient.